List of largest biomedical companies by revenue

The following is a list of the top independent pharmaceutical, biotechnology and medical companies ranked by their revenue generated in (billion dollars) in the respective financial year, it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

The change is the companies relative position in this list, compared to their relative position in the prior year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the previous year, red cells indicate those years where there has been a decrease.

Top pharmaceutical companies with revenue over $10 billion
Rank Chg Company 2021
USD billions		 2020
USD billions		 2019
USD billions		 2018
USD billions		 2017
USD billions		 2016
USD billions		 2015
USD billions		 2014
USD billions		 2013
USD billions		 2012
USD billions
1 Johnson & Johnson
NYSE: JNJ		 93.78[1] 82.59[1] 82.06[2] 81.60[3] 76.50[4] 71.89[5] 70.10[6] 74.30[7] 71.31[8] 67.20[9]
3 Sinopharm
SEHK: 1099		 81.77[10] 71.75[11] 60.18[12] 48.75[13] 43.63[14] 36.56[15] 32.36[16] 28.32[17] 23.61[18] 19.31[19]
2 6 Pfizer
NYSE: PFE		 81.29[20] 41.91[21] 41.17[21] 40.83[21] 52.54[22] 52.82[23] 48.85[24] 49.61[25] 51.58[26] 58.99[27]
4 1 Roche
SIX: ROG		 67.83[28] 62.99[28] 63.85[29] 56.86[30] 57.37[31] 50.11[32] 47.70[33] 49.86[34] 48.53[35] 47.80[36]
5 2 AbbVie
NYSE: ABBV		 56.20[37] 45.80[37] 33.27[38] 32.75[39] 28.22[40] 25.56[41] 22.82[42] 19.96[43] 18.79[44]
6 2 Novartis
NYSE: NVS		 51.63[45] 48.66[45] 47.45[46] 44.75[47] 49.11[48] 48.52[49] 49.41[50] 58.00[51] 57.36[52] 56.67[53]
7 2 Bayer
FWB: BAYN		 49.46[54] 47.40[55] 48.02[56] 45.06[57] 37.94[58] 25.27[59] 24.09[60] 25.47[61] 24.17[62] 24.30[63]
8 2 Merck & Co.
NYSE: MRK		 48.70[64] 41.52[64] 46.84[65] 42.30[66] 40.10[67] 39.80[68] 39.50[69] 42.24[70] 44.03[71] 47.27[72]
9 3 GlaxoSmithKline
LSE: GSK		 46.91[73] 46.17[74] 43.92[75] 43.14[76] 42.05[77] 34.79[78] 29.84[79] 37.96[80] 41.61[81] 39.93[82]
10 2 Bristol Myers Squibb
Nasdaq: BMY		 46.39[83] 42.52[83] 26.15[84] 22.56[85] 20.80[86] 19.43[87] 16.56[88] 15.88[89] 16.39[90] 17.62[91]
11 Sanofi
NYSE: SNY		 43.24[92] 41.27[92] 39.28[93] 39.07[94] 42.91[95] 36.57[96] 36.73[97] 43.07[98] 42.08[99] 46.41[100]
12 Abbott Laboratories
Nasdaq: ABT		 43.08[101] 34.61[102] 31.90[103] 30.60[104] 27.39[105] 20.85[106] 20.41[107] 20.25[108] 21.85[109] 39.87[110]
13 Takeda Pharmaceutical
TYO: 4502		 27.76[111] 31.17[112] 19.10[113] 16.70[114] 15.96[115] 14.93 16.84 17.36 18.91
14/ AstraZeneca
LSE: AZN		 37.42[116] 26.62[117] 24.38[118] 22.09[119] 22.47[120] 23.00[121] 24.71[122] 26.10[123] 25.71[124] 27.97[125]
15 2 Eli Lilly & Co
NYSE: LLY		 28.32[126] 24.54[127] 22.32[128] 21.49[129] 22.90[130] 21.22[131] 20.00[132] 19.62[133] 23.11[134] 22.60[135]
16 Gilead Sciences
Nasdaq: GILD		 27.31[136] 24.69[136] 22.45[137] 22.13[138] 25.70[139] 30.39[139] 32.15[139] 24.47[139] 10.80[139] 9.70[139]
17 2 Amgen
Nasdaq: AMGN		 25.98[140] 25.42[141] 23.40[142] 23.70[143] 22.80[144] 22.99[145] 21.66[146] 20.06[147] 18.68[148] 17.30[149]
18 Boehringer Ingelheim
Private		 22.40[150] 21.75[150] 21.67[151] 17.54[152] 16.41[152] 17.70[152] 18.68[152] 18.89[152]
19 1 Novo Nordisk
NYSE: NVO		 21.66[153] 19.52[153] 18.30[154] 16.99[155] 18.77[156] 16.61[157] 16.06[158] 15.83[159] 14.88[160] 13.48[161]
20 1 Merck Group
ETR: MRK		 21.40[162] 20.08[163] 18.25[164] 16.48[165] 18.70[166] 16.62[167] 14.25[168] 15.29[169] 14.73[166] 14.36[166]
21 2 Siemens Healthineers
FWB: SHL		 20.61[170] 16.56[170] 16.62[171] 15.37[172] 16.56[173] 14.25[173] 14.06[173]
22 Viatris
Nasdaq: VTRS		 17.89[174] 11.95[174]
23 1 GE Healthcare
Subsidiary of General Electric		 17.73[175] 18.01[176] 19.94[177] 19.78[178] 19.02[179] 18.21[180] 17.64[181] 18.30[182] 18.20[183]
24 4 Regeneron Pharmaceuticals
Nasdaq: REGN		 16.07[184] 8.50[184] 7.86[185] 6.71[185] 5.87[185] 4.86[186] 4.10[187] 2.82[187] 2.10[187] 1.38[187]
25 2 Teva Pharmaceuticals
Nasdaq: TEVA		 15.88[188] 16.66[189] 16.89[190] 18.90[191] 22.40[192] 21.90[193] 20.00[194] 20.27[195] 20.31[196] 18.31[197]
26 Baxter International
NYSE: BAX		 12.778[198] 11.63[199] 11.36[199] 11.13 [200] 10.56 [200] 10.16 [201] 9.97 [202] 10.72 [203] 14.97 [204] 14.19 [205]
27 2 Biogen
Nasdaq: BIIB		 10.98[206] 13.44[206] 14.38[207] 13.45[208] 12.30[209] 11.40[210] 10.80[211] 9.70[212] 6.90[213] 5.50[214]
28 1 Astellas Pharma
TYO: 4503		 10.85[215] 11.29[215] 12.27[216] 12.07 12.63 11.48 10.49 9.25 8.92

See also

Notes

    References
    1. https://johnsonandjohnson.gcs-web.com/static-files/5db7df36-78aa-4769-84d4-a49cb3a273ba
    2. "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results: | BioSpace".
    3. "Johnson & Johnson Reports 2018 Fourth-Quarter Results". Content Lab - U.S.
    4. "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
    5. "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
    6. "Johnson & Johnson Reports 2015 Fourth-Quarter Results". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
    7. "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
    8. "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
    9. "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results".
    10. "Sinopharm (1099.HK) - Revenue". companiesmarketcap.com. Retrieved 2022-04-17.
    11. https://media-sinopharm.todayir.com/2021042308080224799730699_en.pdf
    12. "Archived copy" (PDF). Archived from the original (PDF) on 2020-06-27. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
    13. "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-06. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
    14. "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
    15. "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
    16. "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
    17. "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
    18. "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
    19. "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
    20. https://s28.q4cdn.com/781576035/files/doc_financials/2021/q4/Q4-2021-PFE-Earnings-Release.pdf
    21. https://s28.q4cdn.com/781576035/files/doc_financials/2020/AR/PFE-2020-Form-10K-FINAL.pdf
    22. https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf
    23. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf
    24. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf
    25. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf
    26. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf
    27. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf
    28. https://www.roche.com/investors/updates/inv-update-2022-02-03.htm
    29. "Archived copy" (PDF). Archived from the original (PDF) on 2020-01-31. Retrieved 2020-01-31.{{cite web}}: CS1 maint: archived copy as title (link)
    30. "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-07. Retrieved 2019-02-06.{{cite web}}: CS1 maint: archived copy as title (link)
    31. "Roche reports good results in 2017". www.roche.com.
    32. "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    33. "Archived copy" (PDF). Archived from the original (PDF) on 2017-01-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    34. "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-03. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    35. "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-03. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    36. "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-02. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    37. https://investors.abbvie.com/static-files/4805c635-ab17-4c3f-94dd-dc9bf18fbf8c
    38. "AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results".
    39. "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
    40. "Financial Release - AbbVie". investors.abbvie.com.
    41. "Financial Release - AbbVie". investors.abbvie.com.
    42. "Financial Release - AbbVie". investors.abbvie.com.
    43. "Financial Release - AbbVie". investors.abbvie.com.
    44. "Financial Release - AbbVie". investors.abbvie.com.
    45. https://www.novartis.com/sites/novartis_com/files/q4-2021-media-release-en.pdf
    46. https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf
    47. https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf
    48. "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    49. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf
    50. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf
    51. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf
    52. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf
    53. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf
    54. https://www.bayer.com/sites/default/files/2022-03/Bayer-Annual-Report-2021.pdf
    55. https://www.bayer.com/sites/default/files/2021-02/Bayer-Annual-Report-2020.pdf
    56. "Bayer AG Annual Report 2019" (PDF). www.bayer.com.
    57. "Bayer's Annual Report 2018". www.annualreport2018.bayer.com.
    58. http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf
    59. http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf
    60. http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf
    61. AG, Bayer. "Bayer – Global Home". www.bayer.com.
    62. https://www.bayer.com/en/ar-2013.pdfx
    63. https://www.bayer.com/en/ar-2012.pdfx
    64. https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2021-financial-results/
    65. "Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results".
    66. "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
    67. LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket". CNBC.
    68. http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf
    69. http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf
    70. http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf
    71. http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf
    72. http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf
    73. https://www.gsk.com/media/7383/fy-2021-us-dollar-translation.pdf
    74. https://www.gsk.com/media/6662/annual-report-2020.pdf
    75. https://www.gsk.com/media/5820/fy-2019-results-announcement.pdf
    76. "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
    77. https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf
    78. https://www.gsk.com/media/3609/annual-report-2016.pdf
    79. https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf
    80. https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf
    81. https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf
    82. https://www.gsk.com/media/2694/annual-report-2012.pdf
    83. https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2021/BMY-Q42021-Earnings-Press-Release.pdf
    84. https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79
    85. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
    86. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
    87. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
    88. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
    89. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
    90. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
    91. https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf
    92. https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/common/docs/investors/2022_02_04_Sanofi_Q4_FY_2021_iPDF-v3.pdf?la=en
    93. "Fourth quarter and full year 2019 results - Sanofi".
    94. https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560
    95. "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-09. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
    96. https://en.sanofi.com/Images/49288_20-F_2016.pdf
    97. https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf
    98. https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf
    99. https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf
    100. https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf
    101. https://abbott.mediaroom.com/2022-01-26-Abbott-Reports-Strong-Fourth-Quarter-2021-Results-Issues-2022-Forecast
    102. https://www.abbottinvestor.com/static-files/52cadf21-4090-40fd-9857-fa58e1e25949
    103. "Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020".
    104. "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
    105. Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
    106. Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
    107. "Abbott Reports Fourth-Quarter 2015 Results".
    108. "Abbott Reports Fourth-Quarter 2014 Results".
    109. Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
    110. "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
    111. https://www.takeda.com/499b8f/siteassets/system/investors/quarterly-announcements/fy2020/qr2020_q4_qfr_en.pdf
    112. "Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum".
    113. "Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance".
    114. "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
    115. "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).{{cite web}}: CS1 maint: url-status (link)
    116. https://www.astrazeneca.com/content/dam/az/PDF/2021/full-year/Full-year-2021-results-announcement.pdf
    117. https://www.astrazeneca.com/content/dam/az/PDF/2020/full-year/Full-year_2020_results_announcement.pdf
    118. https://www.astrazeneca.com/content/dam/az/PDF/2019/full-year/Full-year_and_Q4_2019_results_announcement.pdf
    119. https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf
    120. https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf
    121. "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-03. Retrieved 2018-02-02.{{cite web}}: CS1 maint: archived copy as title (link)
    122. "Full-Year and Q4 2015 Results". www.astrazeneca.com.
    123. "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
    124. "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
    125. "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
    126. https://investor.lilly.com/static-files/8f2fb9cc-d123-4baf-ace2-23cef51ce0f0
    127. https://investor.lilly.com/static-files/c03e912c-c3fd-49b4-b383-fb0debe5b2f3
    128. https://www.biospace.com/article/releases/lilly-reports-strong-fourth-quarter-and-full-year-2019-financial-results-updates-2020-guidance-for-pending-dermira-acquisition/?s=72
    129. "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
    130. "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
    131. "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
    132. "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
    133. "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
    134. "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
    135. "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
    136. https://investors.gilead.com/static-files/107ab0e3-735c-4760-882f-c3647ea97ce2
    137. https://www.biospace.com/article/releases/gilead-sciences-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72
    138. "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
    139. "Investor Overview". Gilead Sciences.
    140. https://investors.amgen.com/static-files/cc04ca13-faef-4672-a85a-3fd7c1df3c35
    141. https://investors.amgen.com/static-files/c1b90d85-8945-4d11-8d1c-5ddc343fb699
    142. "Amgen Reports Fourth Quarter and Full Year 2019 Financial Results".
    143. "Amgen - Investors - Press Release". investors.amgen.com.
    144. "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
    145. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
    146. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
    147. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
    148. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
    149. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
    150. https://www.boehringer-ingelheim.com/sites/default/files/ARPC/AR_2020/Boehringer-Ingelheim_Summary_Report_2020.pdf
    151. www.boehringer-ingelheim.com https://www.boehringer-ingelheim.com/corporate-profile/our-company/financial-highlights. {{cite web}}: Missing or empty |title= (help)
    152. "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
    153. https://www.novonordisk.com/content/dam/nncorp/global/en/investors/irmaterial/annual_report/2022/novo-nordisk-annual-report-2021.pdf
    154. "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-23. Retrieved 2020-02-12.{{cite web}}: CS1 maint: archived copy as title (link)
    155. "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-22. Retrieved 2019-02-21.{{cite web}}: CS1 maint: archived copy as title (link)
    156. "News details". www.novonordisk.com.
    157. "Archived copy" (PDF). Archived from the original (PDF) on 2017-03-22. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
    158. Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
    159. Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
    160. Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
    161. Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
    162. https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2021-q4/en/2021-Q4-Report-EN.pdf
    163. https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2020-q4/en/2020-Q4-Report-EN.pdf
    164. https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2019-q4/en/2019-Q4-Report-EN.pdf
    165. "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany". www.emdgroup.com.
    166. "404 page - EMD Group". www.emdgroup.com. Archived from the original on 2019-02-08. Retrieved 2019-02-09. {{cite web}}: Cite uses generic title (help)
    167. "Archived copy" (PDF). Archived from the original (PDF) on 2018-06-19. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
    168. "Archived copy" (PDF). Archived from the original (PDF) on 2018-05-30. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
    169. "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
    170. https://cdn0.scrvt.com/0e46935d037de4ec3888566275864b37/df1896911b345f04/bc8ba64c5954/Siemens_Healthineers_Annual-Report_2021.pdf
    171. https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000006835562/12e08501046c/Siemens-Healthineers-Annual-Report-2019.pdf
    172. https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000005904947/ef806566e5ee/Annual-Report-2018.pdf
    173. https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
    174. https://investor.viatris.com/news-releases/news-release-details/viatris-reports-strong-fourth-quarter-and-full-year-2021
    175. https://www.ge.com/sites/default/files/ge_webcast_presentation_01252022.pdf
    176. https://www.ge.com/sites/default/files/GE_AR20_AnnualLetterToShareholders.pdf
    177. "General Electric Healthcare segment revenue 2008-2020".
    178. "General Electric Healthcare segment revenue 2008-2020".
    179. "General Electric Healthcare segment revenue 2008-2020".
    180. "General Electric Healthcare segment revenue 2008-2020".
    181. "General Electric Healthcare segment revenue 2008-2020".
    182. "General Electric Healthcare segment revenue 2008-2020".
    183. "General Electric Healthcare segment revenue 2008-2020".
    184. https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2021-financial
    185. https://investor.regeneron.com/static-files/bc3a2029-09e7-4064-95d6-8f5a2094e161
    186. https://investor.regeneron.com/static-files/04bf9c6c-c0ed-4dcb-ae8c-8c6da6c08d61
    187. https://investor.regeneron.com/static-files/0f20ed34-4570-40e9-8bab-d769e8e3fcab
    188. https://s24.q4cdn.com/720828402/files/doc_financials/2021/q4/Press-Release-Q4-2021.pdf
    189. https://s24.q4cdn.com/720828402/files/doc_financials/2020/q4/FY2020_10K_Feb.10.2021.pdf
    190. "Teva Reports Fourth Quarter and Full Year 2019 Financial Results".
    191. https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf
    192. "Teva Reports 2017 Full Year and Fourth Quarter Financial Results". 8 February 2018.
    193. "Archived copy". Archived from the original on 2018-02-03. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
    194. "Archived copy". Archived from the original on 2018-09-15. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
    195. "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
    196. "Archived copy". Archived from the original on 2018-09-15. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
    197. "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
    198. https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2022/Baxter_Reports_Fourth-Quarter_and_Full-Year_2021_Results_Schedules.pdf
    199. https://s22.q4cdn.com/911189824/files/doc_financials/2020/ar/938b4abc-cc88-48af-83ef-8b67633f01af.pdf
    200. https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2018/q4/Q4-2018-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
    201. https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
    202. https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf
    203. https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf
    204. https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf
    205. https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2012/Reclassified-Sales-Final.pdf
    206. https://investors.biogen.com/static-files/e483fbec-6adb-4bfd-a2c0-e48d488a3256
    207. https://investors.biogen.com/static-files/ce31eed8-8862-4bec-a63f-77c0fd6e15a1
    208. http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e
    209. "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 – via www.bloomberg.com.
    210. "Archived copy" (PDF). Archived from the original (PDF) on 2017-11-18. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    211. "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    212. "Archived copy" (PDF). Archived from the original (PDF) on 2015-10-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    213. "Archived copy" (PDF). Archived from the original (PDF) on 2017-07-13. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    214. "Archived copy" (PDF). Archived from the original (PDF) on 2015-11-06. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
    215. https://www.astellas.com/jp/system/files/astellas_ar2021_en_20211126.pdf
    216. "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.